Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002169
Filing Date
2025-03-04
Accepted
2025-03-04 16:05:38
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rigl-20241231x10k.htm   iXBRL 10-K 3079661
2 EX-10.9 rigl-20241231xex10d9.htm EX-10.9 144961
3 EX-10.16 rigl-20241231xex10d16.htm EX-10.16 62807
4 EX-10.25 rigl-20241231xex10d25.htm EX-10.25 15109
5 EX-10.34 rigl-20241231xex10d34.htm EX-10.34 13437
6 EX-10.35 rigl-20241231xex10d35.htm EX-10.35 444358
7 EX-19.1 rigl-20241231xex19d1.htm EX-19.1 275506
8 EX-23.1 rigl-20241231xex23d1.htm EX-23.1 14967
9 EX-31.1 rigl-20241231xex31d1.htm EX-31.1 14807
10 EX-31.2 rigl-20241231xex31d2.htm EX-31.2 14892
11 EX-32.1 rigl-20241231xex32d1.htm EX-32.1 9981
12 GRAPHIC rigl-20241231x10k003.jpg GRAPHIC 80476
13 GRAPHIC rigl-20241231x10k004.jpg GRAPHIC 29510
14 GRAPHIC rigl-20241231xex10d34001.jpg GRAPHIC 847
15 GRAPHIC rigl-20241231xex10d35002.jpg GRAPHIC 15794
16 GRAPHIC rigl-20241231xex10d35003.jpg GRAPHIC 87799
17 GRAPHIC rigl-20241231xex10d35004.jpg GRAPHIC 122372
18 GRAPHIC rigl-20241231xex19d1001.jpg GRAPHIC 643
19 GRAPHIC rigl-20241231xex19d1002.jpg GRAPHIC 863
  Complete submission text file 0001558370-25-002169.txt   14254553

Data Files

Seq Description Document Type Size
20 EX-101.SCH rigl-20241231.xsd EX-101.SCH 86111
21 EX-101.CAL rigl-20241231_cal.xml EX-101.CAL 77427
22 EX-101.DEF rigl-20241231_def.xml EX-101.DEF 284775
23 EX-101.LAB rigl-20241231_lab.xml EX-101.LAB 707013
24 EX-101.PRE rigl-20241231_pre.xml EX-101.PRE 517209
120 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20241231x10k_htm.xml XML 2345363
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 25704240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)